Clinical Trial Update: Phase II Study of Dexamethasone, Thalidomide and Lenalidomide for Subjects With Relapsed or Refractory Multiple Myeloma [Phase 2]

View source ↗

Summary

Phase II trial evaluating a combination of dexamethasone, thalidomide, and lenalidomide in relapsed or refractory multiple myeloma; the study was terminated wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Lenalidomide (lenalidomide)
• Thalidomide (thalidomide)

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Multiple Myeloma | Phase 2 | Status: TERMINATED | Results posted: 2017-06-08